← Back to Search

Dietary Supplement

Human Milk Fortifier for Premature Birth

N/A

Recruiting

Research Sponsored by Augusta University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at 36 weeks post menstrual age

Awards & highlights

Study Summary

This trial will test whether human milk fortifier given on day 1 helps improve growth velocity at 28 days and 36 weeks post menstrual age.

Eligible Conditions

Premature Birth

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at 36 weeks post menstrual age

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at 36 weeks post menstrual age

This trial's timeline: 3 weeks for screening, Varies for treatment, and at 36 weeks post menstrual age for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Secondary outcome measures

Growth velocity

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: InterventionExperimental Treatment1 Intervention

Introducing human milk fortifier at 1 day

Group II: ControlActive Control1 Intervention

Continue current NICU feeding protocol, introducing human milk fortifier at 8 days

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Human milk fortifier

2011

N/A

~190

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Augusta UniversityLead Sponsor

210 Previous Clinical Trials

84,978 Total Patients Enrolled

Media Library

Human milk fortifier (Dietary Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT05228535 — N/A

Premature Birth Research Study Groups: Control, Intervention

Premature Birth Clinical Trial 2023: Human milk fortifier Highlights & Side Effects. Trial Name: NCT05228535 — N/A

Human milk fortifier (Dietary Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05228535 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is recruitment still open for the study?

"Affirmative. According to the information accessible on clinicaltrials.gov, enrolling for this particular medical trial is currently open; it was initially posted April 11th 2022 and recently updated July 19th 2022. A total of 50 patients are required from one healthcare facility."

Answered by AI

How many participants can be included in this research project?

"Affirmative. Per the information posted on clinicaltrials.gov, this research is actively seeking volunteers to participate in it. The study was first made visible on April 11th 2022 and has since been updated as of July 19th 2022. 50 subjects from a single medical centre need to be recruited for the trial's completion."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Human Milk in Preterm Infants

2022. "Human Milk in Preterm Infants". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05228535.